Beta Drugs Limited (NSE:BETA)
India flag India · Delayed Price · Currency is INR
1,699.25
-3.70 (-0.22%)
At close: Jul 24, 2025

Beta Drugs Revenue

In the fiscal year ending March 31, 2025, Beta Drugs had annual revenue of 3.62B INR with 22.54% growth. Beta Drugs had revenue of 1.82B in the half year ending March 31, 2025, with 58.69% growth.

Revenue
3.62B
Revenue Growth
+22.54%
P/S Ratio
4.76
Revenue / Employee
9.77M
Employees
371
Market Cap
17.26B

Revenue Chart

Created with Highcharts 11.4.8Beta Drugs Revenue - Annual1.16B1.16B1.84B1.84B2.27B2.27B2.96B2.96B3.62B3.62B20212022202320242025-1B2B3B

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20253.62B666.42M22.54%
Mar 31, 20242.96B686.00M30.21%
Mar 31, 20232.27B432.76M23.54%
Mar 31, 20221.84B677.16M58.31%
Mar 31, 20211.16B253.16M27.88%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Reliance Industries9,765.41B
HDFC Bank2,736.06B
Bharti Airtel1,729.85B
Tata Consultancy Services2,561.48B
ICICI Bank2,054.85B
State Bank of India3,429.39B
Infosys1,672.76B
Bajaj Finance370.20B
Revenue Rankings